奈克塔制药 NKTR
$37.26 +$1.11 (+3.07%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $37.26 0.00%
开盘$36.58
昨收$36.15
当日区间$36.44 – $37.58
成交量686.4K
市值$1.27B
市盈率（TTM）–
股息率–
财报
财报日平均波动±5.1%近16次财报
收涨次数7 / 1644% 的概率
最佳反应+10.4%
最差反应-8.9%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 13 Aug 2026 | After Market | ±5.2% | -3.82% | 符合区间 |
| 2026/Q1 | 7 May 2026 | After Market | ±8.5% | -1.78% | 符合区间 |
| 2025/Q4 | 12 Mar 2026 | After Market | ±7.9% | +4.11% | 符合区间 |
| 2025/Q3 | 6 Nov 2025 | After Market | ±15.5% | +1.54% | 符合区间 |
| 2025/Q2 | 7 Aug 2025 | After Market | ±14.6% | +6.02% | 符合区间 |
| 2025/Q1 | 8 May 2025 | After Market | ±40.4% | -4.88% | 符合区间 |
| 2024/Q4 | 12 Mar 2025 | After Market | ±39.8% | -0.56% | 符合区间 |
| 2024/Q3 | 7 Nov 2024 | After Market | ±36.9% | +2.19% | 符合区间 |
| 2024/Q2 | 8 Aug 2024 | After Market | ±58.8% | -8.26% | 符合区间 |
| 2024/Q1 | 9 May 2024 | After Market | ±30.1% | +10.00% | 符合区间 |
| 2023/Q4 | 4 Mar 2024 | After Market | ±47.8% | -1.77% | 符合区间 |
| 2023/Q3 | 7 Nov 2023 | After Market | ±96.7% | -8.76% | 符合区间 |
| 2023/Q2 | 8 Aug 2023 | After Market | ±32.0% | -8.94% | 符合区间 |
| 2023/Q1 | 9 May 2023 | After Market | ±35.1% | -2.42% | 符合区间 |
| 2022/Q3 | 3 Nov 2022 | None | ±27.7% | +5.90% | 符合区间 |
| 2022/Q2 | 4 Aug 2022 | After Market | ±19.9% | +10.41% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$10.13M-9.3% YoY
营业利润-$41.76M-16.7% YoY
净利润-$40.62M+2.3% YoY
摊薄每股收益-$1.23+58.3% YoY
自由现金流-$75.86M-65.7% YoY
经营现金流-$75.77M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
营业利润率-239.3%
净利率-287.8%
净资产收益率-35.8%
资产收益率-24.1%
投入资本回报率-28.5%
流动比率10.42
负债/资产比率17.5%
现金及投资$684.34M
总负债$55.85M
净现金（净负债）$628.49M
暂无评论——快来第一个聊聊 NKTR。